Research progress on the mechanism of tumor cell ferroptosis regulation by epigenetics

Area of Science:

• Oncology
• Cell Biology
• Epigenetics

Background:

• Cancer is a major cause of mortality, with chemotherapy facing challenges like drug resistance and cellular toxicity.
• Regulated cell death (RCD) is a programmed process offering therapeutic potential.
• Ferroptosis, a distinct iron-dependent RCD, involves lipid peroxidation and mitochondrial damage, differing from apoptosis, autophagy, and necroptosis.

Purpose of the Study:

• To review the role of epigenetic factors in regulating tumor cell ferroptosis.
• To explore the mechanisms by which epigenetics influences ferroptosis in cancer.
• To discuss potential applications of targeting epigenetic regulation of ferroptosis in cancer therapy.

Main Methods:

• Literature review synthesizing current knowledge on epigenetic regulation of ferroptosis.
• Analysis of mechanisms linking epigenetic factors to ferroptosis pathways.
• Discussion of implications for cancer treatment strategies.

Main Results:

• Epigenetic modifications influence key regulators of ferroptosis, including iron metabolism and lipid peroxidation.
• Dysregulation of epigenetic factors can promote or inhibit ferroptosis in tumor cells.
• Targeting epigenetic mechanisms offers a promising strategy to induce ferroptosis and overcome drug resistance.

Conclusions:

• Epigenetic regulation plays a critical role in tumor cell ferroptosis.
• Understanding these epigenetic mechanisms is essential for developing novel cancer therapies.
• Targeting epigenetics to modulate ferroptosis holds significant potential for improving cancer treatment efficacy.